MGIA
Moneta Group Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Buy |
4,501
+599
| +15% | +$75.8K | 0.01% | 409 |
|
|
2025
Q1 | $499K | Sell |
3,902
-149
| -4% | -$19.1K | 0.01% | 420 |
|
|
2024
Q4 | $536K | Sell |
4,051
-34
| -0.8% | -$4.5K | 0.01% | 399 |
|
|
2024
Q3 | $595K | Buy |
4,085
+283
| +7% | +$41.2K | 0.01% | 373 |
|
|
2024
Q2 | $522K | Sell |
3,802
-76
| -2% | -$10.4K | 0.01% | 385 |
|
|
2024
Q1 | $532K | Sell |
3,878
-546
| -12% | -$74.9K | 0.01% | 365 |
|
|
2023
Q4 | $601K | Sell |
4,424
-115
| -3% | -$15.6K | 0.01% | 310 |
|
|
2023
Q3 | $555K | Buy |
4,539
+1
| +0% | +$122 | 0.01% | 296 |
|
|
2023
Q2 | $576K | Sell |
4,538
-46
| -1% | -$5.84K | 0.01% | 296 |
|
|
2023
Q1 | $592K | Buy |
4,584
+399
| +10% | +$51.5K | 0.01% | 283 |
|
|
2022
Q4 | $571K | Buy |
4,185
+791
| +23% | +$108K | 0.02% | 274 |
|
|
2022
Q3 | $397K | Sell |
3,394
-500
| -13% | -$58.5K | 0.02% | 303 |
|
|
2022
Q2 | $458K | Buy |
3,894
+1,223
| +46% | +$144K | 0.02% | 310 |
|
|
2022
Q1 | $348K | Buy |
2,671
+574
| +27% | +$74.8K | 0.01% | 335 |
|
|
2021
Q4 | $320K | Buy |
2,097
+705
| +51% | +$108K | 0.01% | 371 |
|
|
2021
Q3 | $225K | Buy |
1,392
+133
| +11% | +$21.5K | 0.01% | 417 |
|
|
2021
Q2 | $206K | Buy |
+1,259
| New | +$206K | 0.01% | 429 |
|
|
2018
Q3 | – | Sell |
-775
| Closed | -$85K | – | 297 |
|
|
2018
Q2 | $85K | Buy |
+775
| New | +$85K | 0.01% | 292 |
|
|
2015
Q2 | – | Sell |
-2,000
| Closed | -$687K | – | 140 |
|
|
2015
Q1 | $687K | Hold |
2,000
| – | – | 0.29% | 68 |
|
|
2014
Q4 | $607K | Hold |
2,000
| – | – | 0.29% | 59 |
|
|
2014
Q3 | $547K | Hold |
2,000
| – | – | 0.28% | 61 |
|
|
2014
Q2 | $514K | Hold |
2,000
| – | – | 0.28% | 60 |
|
|
2014
Q1 | $473K | Hold |
2,000
| – | – | 0.28% | 59 |
|
|
2013
Q4 | $454K | Hold |
2,000
| – | – | 0.27% | 63 |
|
|
2013
Q3 | $419K | Buy |
2,000
+500
| +33% | +$105K | 0.28% | 66 |
|
|
2013
Q2 | $261K | Buy |
+1,500
| New | +$261K | 0.18% | 91 |
|